Selectively targeting key inflammatory pathways in cystic fibrosis
- 1 November 2020
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 206, 112717
Abstract
No abstract availableKeywords
Funding Information
- Fondazione per la Ricerca sulla Fibrosi Cistica
- European Research Council
This publication has 68 references indexed in Scilit:
- Malfolded Protein Structure and Proteostasis in Lung DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 2014
- Autophagy Enhances Bacterial Clearance during P. aeruginosa Lung InfectionPLOS ONE, 2013
- Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lungNature, 2012
- Proteostasis: A New Therapeutic Paradigm for Pulmonary DiseaseProceedings of the American Thoracic Society, 2011
- An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T CellsThe Journal of Immunology, 2010
- Non-hematopoietic cells contribute to protective tolerance to Aspergillus fumigatus via a TRIF pathway converging on IDOCellular & Molecular Immunology, 2010
- The aryl hydrocarbon receptor: a perspective on potential roles in the immune systemImmunology, 2009
- Protection against Lethal Challenge withStreptococcus pneumoniaeIs Conferred by Aryl Hydrocarbon Receptor Activation but Is Not Associated with an Enhanced Inflammatory ResponseInfection and Immunity, 2006
- Thymosin α1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and toleranceBlood, 2006
- Effect of High-Dose Ibuprofen in Patients with Cystic FibrosisNew England Journal of Medicine, 1995